Clinical Trial Update: Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes that Phase 2 and Phase 3 studies of supplemental oxygen for prethreshold retinopathy of prematurity have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 2, Phase 3 | Status: COMPLETED